In this study, 27 volunteers received one of three non-O group 1 Vibrio cholerae strains in doses as high as 109 CFU. Only one strain (strain C) caused diarrhea: this strain was able to colonize the gastrointestinal tract, and produced a heat-stable enterotoxin (NAG-ST). Diarrhea was not seen with a strain (strain A) that colonized the intestine but did not produce NAG-ST, nor with a strain (strain B) that produced NAG-ST but did not colonize. Persons receiving strain C had diarrhea and abdominal cramps. Diarrheal stool volumes ranged from 154 to 5,397 ml; stool samples from the patient having 5,397 ml of diarrhea were tested and found to contain NAG-ST. The median incubation period for illness was 10 h. There was a suggestion that occurrence of diarrhea was dependent on inoculum size. Immune responses to homologous outer membrane proteins, lipopolysacchide, and whole-cell lysates were demonstrable with all three strains.
Introduction
Vibrio cholerae are classified according to 0 group (1) (2) (3) , with strains of 0 group 1 (V. cholerae 01)1 responsible for the disease cholera (4, 5) . The role played by strains of0 groups other 1. Abbreviations used in this paper: ASC, antibody-secreting cell, BHIA, brain-heart infusion agar, CFA, colonization factor antigen; CHO, Chinese hamster ovary; CT, cholera toxin; ETEC, enterotoxigenic Escherichia coli; FA, fluid accumulation; NAG-ST, heat-stable enterotoxin produced by strains of non-Ol V. cholerae; OMP, outer membrane protein; RBC, red blood cell; RITARD, removable intestinal tie-adult rabbit diarrhea; V cholerae 01, 0 group I Vibrio cholerae. than 1 (non-Ol or nonagglutinable [NAG] V. cholerae) in human disease is much less clear. Non-Ol strains have been implicated in outbreaks of foodborne disease (6, 7) , isolated from as many as 13% of patients with cholera-like disease during cholera epidemics (8) (9) (10) , and identified in stool samples from patients with gastroenteritis in Asia (1 1, 12), Africa (1 3j, Europe (14) , Australia, and North (15, 16) and South (17) America. They are also ul.iquitous in estuarine environments (including bays and estuaries of the U. S. Gulf, Atlantic, and Pacific coasts) and commonly are isolated from shellfish: a study conducted by the U. S. Food and Drug Administration found non-01 V. cholerae in up to 37% of U. S. oyster lots harvested during warm, summer months (18) .
Although clinical observations suggest that non-0 1 V. cholerae cause diarrhea, the number of reported cases of non-0 1 disease in the United States is much less than might be anticipated (4, 19) , given the amount of shellfish consumed and the frequency with which the organism is present in shellfish. In the absence of clear data to the contrary, it could be hypothesized that non-O 1 V. cholerae are simply commensals that do not cause disease. If non-0 1 strains do cause illness, the small number of reported cases may be due to differences in host susceptibility, or reflect the need for a high infectious dose (4) . Alternatively, perhaps only a minority of strains, carrying specific virulence factors, are able to cause disease.
Proposed virulence factors for non-0 1 V. cholerae have included toxins similar to cholera toxin (12, (20) (21) (22) , the El Tor (23) (24) (25) and Kanagawa (26) hemolysins, a Shiga-like toxin (27) , various cell-associated hemagglutinins (22, 28) , and a 17-amino acid, heat-stable enterotoxin (designated NAG-ST), which closely resembles the heat-stable toxin produced by enterotoxigenic strains ofEscherichia coli (26, (29) (30) (31) . It has also been suggested that virulence is dependent on the ability of a non-0 1 V. cholerae strain to colonize the intestine, as demonstrated in rabbits using the removable intestinal tie-adult rabbit diarrhea (RITARD) model (32) . In an effort to determine if non-01 V. cholerae are indeed pathogenic and to investigate the importance of purported virulence factors in disease, we administered three non-01 strains to a total of 27 volunteers. These are the first such volunteer studies ever conducted with non-0 1 V. cholerae strains.
Methods

Characterization ofstrains
For these studies three strains of non-01 V. cholerae were employed (Table I) : 2076-79 (designated as strain A), isolated from a patient with diarrhea living in Mississippi who had eaten raw oysters (15) ; A-5 (strain B), isolated from frozen shrimp in Japan (29) ; and NRT36S (strain C), isolated from a patient with traveler's diarrhea seen at the quarantine station at Narita Airport, Tokyo. Species identity was con- Hemagglutination/fimbriae/colonization factors. Hemagglutination assays were performed as described by Shehabi et al. (28) , using fresh human type 0, rabbit, and sheep RBC; results are summarized in Table I . The hemagglutination response in each instance was inhibited by the addition of 1% D-mannose.
Strain A had fimbriae as demonstrated by electron microscopy ( Fig. 1 ). Fimbriae were most prominent when cells were grown on colonization factor antigen (CFA) agar with 66 mM NaCl (39, 40) ; however, fimbriae were also demonstrable after growth on brain-heart infusion agar (BHIA) . Similar attempts to demonstrate fimbriae on strain B or C were unsuccessful. In hybridization studies conducted by Dr. Ronald Taylor, University of Tennessee Health Science Center, Memphis, none of the strains carried the structural gene for the TcpA pilus, the major colonization factor for V. cholerae 01 in humans (41, 42 (47) . LPS was extracted using a modification of the standard Westphal and Jann procedure (48) . For OMP, LPS, and whole-cell lysates, serial twofold dilutions ofeach sample were tested, and the antibody titer was defined as the last dilution giving a corrected OD reading of 2 0.15; persons showing a fourfold or greater rise in titer were considered to have a positive response. Serum samples were also screened for the presence of vibriocidal antibodies (49) to the homologous strain.
Volunteers receiving strain C were screened for the presence of antibody-secreting cells (ASC) in blood samples collected on days 0, 7, and 14, using an ELISA to identify specific IgG and IgA antibodies produced in vitro by peripheral blood lymphocytes (50) . Briefly, 96-well polyvinyl microtiter ELISA plates were coated with our OMP preparation at a concentration of 2 utg/ml. Plates were washed and blocked with 0.05% bovine serum albumin, and 100 Al (I06) of peripheral blood lymphocytes obtained by centrifugation of heparinized venous blood on Ficoll-Paque (Pharmacia, Uppsala, Sweden) were added to replicate wells on the plates. After incubation at 370C for 16 h, appropriate enzyme-conjugated class-specific antisera and substrate were added (50) , and the amount of OMP-specific antibody produced was expressed as an OD (absorbance at 405 nm). A positive response was defined as an increase in OD of > 2 SD from the mean of values obtained with prechallenge (day 0) lymphocytes.
Results
For our volunteer studies we initially selected strain A: it was a clinical isolate, gave a strong positive response in our RITARD model, and carried a number of purported virulence factors. As summarized in Table II , strain A was administered to volunteers in sequential studies at doses of 106, 1O', 108, and 1O' CFU. Of the 13 volunteers, 10 excreted the organism in their stool or had positive duodenal string capsule cultures (Table  III) . Stool excretion persisted for days, with six volunteers still culture-positive for non-O1 V. cholerae when therapy with tetracycline was initiated. However, none had diarrhea or any other complaint. Eight volunteers had a serologic response to the organism, as evidenced by a fourfold rise in titer to homologous OMP or LPS preparations (Table IV) was seen between initial antibody titer and subsequent excretion of non-O1 V. cholerae. In evaluating our data after this initial set of studies we noted that strain A did not produce NAG-ST, leading to the hypothesis that NAG-ST was an important virulence factor for non-Ol V. cholerae. To test this hypothesis, we obtained strain B, an environmental strain that was used in one of the initial descriptions of NAG-ST (29) . This strain was administered to volunteers in sequential studies at doses of 107 and 109 CFU. None of the volunteers had a positive duodenal string capsule or stool culture (Table III) . None had diarrhea, although two complained of mild abdominal cramps. None had antibodies directed against NAG-ST; three of four had a serologic response to an OMP preparation from the homologous strain.
These results led to the hypothesis that virulence was dependent both on the ability of a strain to colonize the intestine and on the elaboration of a toxin such as NAG-ST. To test this hypothesis, we obtained strain C, a clinical isolate that produced high levels of NAG-ST and colonized and caused disease in our rabbit model. Strain C was initially administered at a dose of 107 CFU. One of two volunteers receiving this dose had diarrhea, with a total stool volume of 242 ml. When we administered 109 CFU, all three volunteers developed diarrhea and abdominal cramps, with diarrheal stool volumes of 2,091, 276, and 253 ml, respectively. The frequency ofillness differed significantly when persons receiving 109 CFU of strain C were compared with those receiving 109 CFUJ of strain A (P = 0.03, Fisher's exact test).
In an effort to better define the infectious dose for this strain, we then administered strain C to volunteers in doses of 10' and 106. Persons receiving 105 CFU were asymptomatic. One of three volunteers receiving 106 CFU had minimal diarrhea (140 ml), without abdominal cramps (Table II) ; a second complained of abdominal cramps, but had no diarrhea. The third volunteer receiving 106 CFU had a total diarrheal stool volume of 5,397 ml. This volunteer had 1,970 ml of diarrhea and over 600 ml of emesis during the first 4 h of illness. Intravenous rehydration was initiated at this point, and the volunteer was started on therapy with tetracycline; during the next 22 h she had an additional 3,420 ml of diarrhea. If uncorrected, fluid losses associated with her diarrhea would have represented a fluid deficit of -9% of her admission weight. Diarrheal stools assumed the characteristic "rice water" appearance seen in severe cases of cholera within 3 h of onset of illness.
Stool samples collected 4, 7, and 12.5 h after onset of illness in the volunteer who had 5,397 ml of diarrhea were screened for the presence of NAG-ST. At a 5X concentration, FA ratios for these samples were 0.070, 0.057, and 0.094, respectively (average of at least two determinations). FA activity was unaffected by heat (1000C, 10 min) but was neutralized by a monoclonal antibody directed against NAG-ST. By competitive ELISA, NAG-ST could be clearly demonstrated in the 12.5-h sample. In keeping with our inclusion criteria for vol- unteers, this volunteer was in excellent health with no underlying illnesses, had had no abdominal surgery, and had taken no medications in the 4 wk preceding the study; she did report having taken several courses of tetracycline during the preceeding year for acne. The median incubation period for illness with strain C was 10 h (range 5.5-96 h); there was no obvious association between incubation period and inoculum size. None of the volunteers were febrile, and none had grossly bloody or hemepositive diarrhea. Diarrhea tended to be short-lived, with a median duration of 21 h (range 3.5-48 h). There was a suggestion that diarrhea was more likely to result with higher bacterial inocula (P = 0.06, x2 test for trend).
There was no clear difference in initial antibody titers when persons who became ill were compared with other persons receiving strain C or with persons receiving strains A or B. With the exception of one person receiving 105 CFU, all volunteers receiving strain C showed a serum IgG or IgA response to LPS, OMP, or whole-cell lysates. None of the volunteers receiving strain C had antibodies to NAG-ST. The eight volunteers receiving > 106 CFU of strain C were screened for the presence oflymphocytes secreting specific anti-OMP antibody (ASC assay). In samples obtained on day 7, six volunteers (five ofwhom developed diarrhea) had circulating lymphocytes that produced IgA directed against homologous OMP; this response had returned to baseline levels by day 14. Only three of the six with a positive ASC response had a rise in anti-OMP IgA antibody titer by ELISA.
Discussion
Our data clearly demonstrate that non-O1 V. cholerae can cause diarrheal disease in otherwise healthy persons. The clinical syndrome seen among persons receiving strain C (short incubation period, frequent and often severe abdominal cramps, short duration of illness) was very similar to that described in non-O 1 V. cholerae-associated foodborne disease outbreaks. In a foodborne outbreak reported from Australia the mean incubation period was 11.5 h (range 5.25-37.5 h); severe abdominal cramps were reported, with diarrhea lasting 18-24 h (6). In a Czechoslovakian outbreak the incubation period was estimated to be 20-30 h, with symptoms resolving in the majority of cases in < 24 h (7). In contrast, U. S. studies based solely on reported cases have tended to describe a more severe clinical syndrome. In one study of sporadic cases of non-Ol V. cholerae gastroenteritis reported to the Centers for Disease Control (15), median duration of illness was 6.4 d, with 7 of 14 patients requiring hospitalization. In this same study a quarter of patients reported bloody diarrhea; none of our volunteers had either grossly bloody or heme-positive stools. Bacteremia due to non-O1 V. cholerae has also been described, with reported mortality rates exceeding 60% (51) . None of our volunteers were bacteremic; case reports suggest that bacteremia is limited primarily to persons who are immunocompromised or have underlying liver disease (51) .
While the illness that we observed was generally mild, two volunteers had over 2 liters of diarrhea, including one with a stool volume of 5,397 ml. In this latter case therapy with tetracycline was started shortly after onset of illness; this volunteer may have had even more severe diarrhea had antibiotic therapy not been so prompt (52) . Fluid deficits totaling 12% or more of body weight in cholera patients are usually fatal in the absence of appropriate rehydration therapy (53) . The purge experienced by our volunteer did not reach this value, but was clearly equivalent to that seen in severe cases of cholera (cholera gravis). There was no obvious explanation for this volunteer having had such severe disease: she was in excellent health, with no underlying illnesses. There are anecdotal data (54) suggesting that use of ,-lactam antibiotics increases susceptibility to infection with Aeromonas hydrophilia, another member of the Vibrionaceae. While our volunteer had taken no medications for 4 wk preceding the non-O1 V. cholerae challenge, her prior use of tetracycline may have in some way affected her normal gastrointestinal flora and, in turn, in-creased her susceptibility to illness. It should be noted, however, that V. cholerae 0 1 strains often produce a similar wide range of clinical response among volunteers (Levine, M. M., personal communication).
Persons recovering from cholera generally develop high vibriocidal antibody titers, together with antibodies directed against cholera toxin (49); half will show an immune response to outer membrane proteins of the homologous strain (55). Our non-Ol strains did not elicit a vibriocidal response, in agreement with observations made during a small outbreak of non-Ol V. cholerae gastroenteritis in Florida (Morris, J. G., unpublished data). Our failure to show an immune response to NAG-ST was also not unexpected, because heat-stable enterotoxin produced by enterotoxigenic E. coli (ETEC) is generally regarded as nonimmunogenic or poorly immunogenic (56, 57) . The majority of volunteers did show a rise in titer to homologous LPS, OMP, or whole-cell lysates, with an even higher number of responders identified by our more sensitive assay for circulating ASC (50, 58 (59) . The antibodies directed against killed V. cholerae 01 provide some protection against subsequent disease (59, 60) . In the absence of rechallenge studies, we can not say whether the antibodies we detected would be similarly protective.
Strains A and C were present in stool samples from volunteers for at least 5 d after bacterial challenge and were recovered from duodenal string capsule cultures. Strain B was administered in comparable doses ( 109 CFU) but was not recovered from stool or duodenal cultures. These results strongly suggest that strains A and C were able to colonize our volunteers, whereas strain B (an environmental strain) was not. This parallels observations made in rabbits: strains from clinical sources were able to colonize the rabbit intestine in the RI-TARD model (with resulting diarrhea), whereas environmental isolates were not (32) . Fimbriae play a critical role in gastrointestinal colonization by ETEC (ETEC) and V. cholerae 01 (41, 42, 61) . Strain A did produce fimbriae, although not the TcpA fimbriae that appear to be essential for V. cholerae 01 colonization (42 (65, 66) . However, the factors or toxins responsible for cytotoxicity do not appear to be directly associated with human disease: strain C, which caused illness, was the least cytotoxic of the three challenge strains in the cell lines tested. Similarly, our data do not support the hypothesis that Shiga-like toxin (27) (37) , providing further evidence that the hemolysin is not a critical virulence factor for humans.
Some non-0 1 V. cholerae strains produce CT or a CT-like toxin (12, (20) (21) (22) , with studies of hospitalized patients in Bangladesh suggesting that persons infected with CT-positive strains have more severe symptoms than those infected with strains that do not produce CT (12) . We did not include CTproducing strains in this study, and consequently cannot comment on the possible role of CT in virulence. Similarly, none of our strains carried the thermostable direct (or Kanagawa) hemolysin, a marker for virulence for V. parahaemolyticus (4) that has been identified in 10% of clinical non-Ol V. cholerae strains isolated in Japan (26) . Our (Fig. 2) . The role of STh and STp in production of human and porcine diarrheal illness, respectively, is well established (57, 68, 69 
